We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.61B
AUM Growth
+$36.4M
Cap. Flow
+$97.7M
Cap. Flow %
6.05%
Top 10 Hldgs %
61.46%
Holding
387
New
81
Increased
131
Reduced
147
Closed
19

Top Buys

Rank Stock Value
1
ASX icon
ASE Group
ASX
+$22.6M
2
MSFT icon
Microsoft
MSFT
+$12.4M
3
AAPL icon
Apple
AAPL
+$9.73M
4
NVDA icon
NVIDIA
NVDA
+$9.56M
5
AMZN icon
Amazon
AMZN
+$6.91M

Top Sells

Rank Stock Value
1
SE icon
Sea Limited
SE
+$20.8M
2
AMD icon
Advanced Micro Devices
AMD
+$16.3M
3
TSM icon
TSMC
TSM
+$7.3M
4
PDD icon
Pinduoduo
PDD
+$2.71M
5
WB icon
Weibo
WB
+$2.43M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 40.2%
2 Technology 29.79%
3 Communication Services 9.9%
4 Healthcare 5.71%
5 Real Estate 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEP icon
176
American Electric Power
AEP
$66.6B
$446K 0.03%
5,181
-45
-0.9% -$3.66K
BPMC
177
DELISTED
Blueprint Medicines
BPMC
$445K 0.03%
4,695
-1,798
-28% -$154K
NTRA icon
178
Natera
NTRA
$47B
$445K 0.03%
4,866
-3,394
-41% -$255K
CERE
179
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$444K 0.03%
10,506
+2,907
+38% +$122K
IMVT icon
180
Immunovant
IMVT
$8.51B
$442K 0.03%
13,675
+1,419
+12% +$51.8K
CCL icon
181
Carnival Corporation Ltd
CCL
$33.9B
$442K 0.03%
27,038
– –
BMRN icon
182
BioMarin Pharmaceuticals
BMRN
$12.5B
$440K 0.03%
5,042
-126
-2% -$11.3K
ALPN
183
DELISTED
Alpine Immune Sciences Inc
ALPN
$439K 0.03%
+11,087
New +$327K
FAST icon
184
Fastenal
FAST
$57.1B
$434K 0.03%
11,264
-116
-1% -$4.1K
DASH icon
185
DoorDash
DASH
$103B
$434K 0.03%
3,152
-39
-1% -$4.59K
RVMD icon
186
Revolution Medicines
RVMD
$44.6B
$433K 0.03%
13,438
-6,094
-31% -$181K
VRT icon
187
Vertiv
VRT
$99B
$430K 0.03%
+5,267
New +$331K
NBIX icon
188
Neurocrine Biosciences
NBIX
$15.7B
$429K 0.03%
3,113
-983
-24% -$134K
PAYX icon
189
Paychex
PAYX
$45.2B
$429K 0.03%
3,495
-53
-1% -$6.43K
ROIV icon
190
Roivant Sciences
ROIV
$25.1B
$428K 0.03%
40,576
-8,284
-17% -$89.3K
IONS icon
191
Ionis Pharmaceuticals
IONS
$10.1B
$426K 0.03%
9,825
-40
-0.4% -$1.91K
ALT icon
192
Altimmune
ALT
$605M
$425K 0.03%
+41,709
New +$424K
VCEL icon
193
Vericel Corp
VCEL
$2.1B
$424K 0.03%
8,145
+2,462
+43% +$108K
INSM icon
194
Insmed
INSM
$25.9B
$423K 0.03%
15,577
-1,601
-9% -$44.8K
HALO icon
195
Halozyme
HALO
$12B
$422K 0.03%
10,385
-1,638
-14% -$61.4K
DNLI icon
196
Denali Therapeutics
DNLI
$3.84B
$422K 0.03%
20,552
+3,262
+19% +$61.3K
ALNY icon
197
Alnylam Pharmaceuticals
ALNY
$31.7B
$421K 0.03%
2,814
-526
-16% -$87.7K
SNDX icon
198
Syndax Pharmaceuticals
SNDX
$1.74B
$420K 0.03%
17,638
-3,942
-18% -$87.9K
KHC icon
199
Kraft Heinz
KHC
$30.5B
$419K 0.03%
11,353
-280
-2% -$10.2K
IRWD icon
200
Ironwood Pharmaceuticals
IRWD
$682M
$419K 0.03%
48,097
+10,410
+28% +$126K
6 7
8
9 10

Similar funds

ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
MAM
Magellan Asset Management Sydney, Australia $4.47B AUM 4.2% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
BP
BC Partners New York $4.43B AUM 49.12% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

E Fund Management's Q1 2024 Portfolio in Review

As of Q1 2024, E Fund Management held 387 positions worth $1.61B, up 2.3% from $1.58B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

E Fund Management deployed $97.7M of net new capital in Q1 2024, opening 81 new positions and adding to 131 existing holdings. Its largest new stake was ASE Group: 2,300,000 shares worth $25.3M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 50% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Sea Limited, an estimated $20.8M trimmed.

  • E Fund Management's largest Q1 2024 buy was ASE Group: 2,300,000 shares worth $25.3M.
  • E Fund Management added most to Microsoft in Q1 2024, an estimated $12.4M increase.
  • E Fund Management's biggest Q1 2024 reduction was Sea Limited, cutting an estimated $20.8M.
  • E Fund Management fully exited Hesai Group in Q1 2024, selling an estimated $1.52M.
  • E Fund Management's ten largest holdings make up 61% of its $1.61B portfolio in Q1 2024.
  • E Fund Management opened 81 new positions and closed 19 in Q1 2024.
  • E Fund Management's portfolio value rose 2.3% quarter-over-quarter to $1.61B.

Based on E Fund Management's 13F filing for Q1 2024, filed 13 May 2024.